CLINICAL MEDICAL POLICY

Similar documents
Cardiac Rehabilitation Services

Related Policies None

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

OTHER AND UNSPECIFIED DISORDERS

Cardiac Rehabilitation in the Outpatient Setting Section 8.0 Therapy Subsection 8.03 Rehabilitation

2017 CMS Web Interface

Obesity/Morbid Obesity/BMI

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Clinical Practice Guideline for the Management of Obesity in Adults

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

2017 CMS Web Interface

Completing the NPA online Patient Safety Incident Report form: 2016

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

Weight Assessment and Counseling for Children and Adolescents (NQF 0024)

Commissioning Policy: South Warwickshire CCG (SWCCG)

US Public Health Service Clinical Practice Guidelines for PrEP

Osteoporosis Fast Facts

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

CDC Influenza Division Key Points MMWR Updates February 20, 2014

Swindon Joint Strategic Needs Assessment Bulletin

Indications and Limitations of Coverage and/or Medical back to top

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

Pediatric and adolescent preventive care and HEDIS *

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Assessment criteria for Primary Health Disciplines Eligibility for Recognition as Credentialled Diabetes Educator. December 2015 ADEA

Solid Organ Transplant Benefits to Change for Texas Medicaid

Lifestyle Modification Program for Reversing Heart Disease Effective Date November 26, 2014

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

COPD Outreach Program

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

Novel methods and approaches for sensing, evaluating, modulating and regulating mood and emotional states.

Clinical Orthopaedic Rehabilitation Spinal Disorders

Fee Schedule - Home Health Care- 2015

DRAFT Policy for the Management of Ear Wax

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)

A. Catalonia World Health Organization Demonstration Project

CDC Influenza Technical Key Points February 15, 2018

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

CONTACT: Amber Hamilton TYPE 2 DIABETES AND OBESITY: TWIN EPIDEMICS OVERVIEW

Lee County Florida Income Guideline Chart

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

2017 CMS Web Interface

Referral Criteria: Inflammation of the Spine Feb

LTCH QUALITY REPORTING PROGRAM

Corporate Governance Code for Funds: What Will it Mean?

Methadone Maintenance Treatment for Opioid Dependence

Evaluation of Hunter & New England HealthPathways

QUALITY AND SAFETY MEASURES UPDATE January 2016

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

WHAT IS HEAD AND NECK CANCER FACT SHEET

Original Policy Date 12:2013

World Confederation for Physical Therapy Congress , May Singapore

EAGLE CARE A SPORT CLUB CONCUSSION MANAGEMENT MODEL

Service Change Process. Gateway 1 High-level Proposition. Innovation project name: Patient Self-Monitoring/Management of Warfarin

Independent Charitable Patient Assistance Program (IPAP) Code of Ethics

Percutaneous Nephrolithotomy (PCNL)

For our protection, we require verification that you have received this notice. Therefore, please sign below.

Diabetes: HbA1c Poor Control (NQF 0059)

2018 CMS Web Interface

1100 Marie Mount Hall College Park, Maryland Tel: (301) Fax: (301)

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

Hearing Service Fees and Fee Codes Effective: January 01, 2019

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

ACSQHC National Consensus Statement: Essential Elements for High Quality End-oflife Care in Acute Hospitals.

For our protection, we require verification that you have received this notice. Therefore, please sign below.

Hospital Preparedness Checklist

Memory Care Community Standards

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

Clinical Study Synopsis

HIP REPLACEMENT SURGERY (ARTHROPLASTY)

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

Patterns of Cholesterol Distribution in the Participants of a Screening Project

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

PSYCHOSEXUAL ASSESSMENTS for Children and Adolescents with Problematic Sexual Behavior. Who is qualified to conduct a psychosexual evaluation?

Coding. Training Guide

Injury, Incident & Illness Procedure

Lower Extremity Amputation (LEA) Considerations / Issues

Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid

DISCUSSION DRAFT DEVENTER, OCTOBER 2006 Consolidation of documents due for revision

EXECUTIVE SUMMARY INNOVATION IS THE KEY TO CHANGING THE PARADIGM FOR THE TREATMENT OF PAIN AND ADDICTION TO CREATE AN AMERICA FREE OF OPIOID ADDICTION

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

Medical Director of Palliative Care INFORMATION PACK

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Transcription:

Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019 Issue Date: 02/18/2019 Effective Date: 02/18/2019 Annual Apprval Date: 12/11/2019 Revisin Date: Prducts: Applicatin: N/A Page Number(s): 1 f 6 Highmark Health Optins Medicaid All participating hspitals and prviders DISCLAIMER Highmark Health Optins medical plicy is intended t serve nly as a general reference resurce regarding cverage fr the services described. This plicy des nt cnstitute medical advice and is nt intended t gvern r therwise influence medical decisins. POLICY STATEMENT Highmark Health Optins may prvide cverage under the therapy benefits f the Cmpany s Medicaid prducts fr medically necessary supervised exercise therapy (SET) fr the treatment f patients with symptmatic peripheral artery disease (PAD). This plicy is designed t address medical necessity guidelines that are apprpriate fr the majrity f individuals with a particular disease, illness r cnditin. Each persn s unique clinical circumstances warrant individual cnsideratin, based upn review f applicable medical recrds. The qualificatins f the plicy will meet the standards f the Natinal Cmmittee fr Quality Assurance (NCQA) and the Delaware Department f Health and Scial Services (DHSS) and all applicable state and federal regulatins. Plicy N. MP-077-MD-DE Page 1 f 6

DEFINITIONS Intermittent claudicatin (vascular claudicatin) A symptm that describes muscle pain r mild exertin, classically in the calf muscle, which ccurs during exercise, such as walking, and is relieved by a shrt perid f rest. PROCEDURES 1. Medical Necessity Guidelines Highmark Health Optins may prvide cverage fr up t 36 sessins ver a 12-week perid if all f the fllwing cmpnents f a SET prgram are met: A. The prgram must cnsist f sessins lasting 30-60 minutes cmprising a therapeutic exercise-training prgram fr PAD in members with claudicatin; AND B. The prgram must be cnducted in a hspital utpatient setting, ambulatry utpatient r a physician s ffice; AND C. The prgram must be delivered by qualified auxiliary persnnel t ensure benefits exceed harms, and wh are trained in exercise therapy fr PAD; AND D. The member must be under the supervisin f a physician, physician assistant, r nurse practitiner/clinical nurse specialist trained in bth basic and advanced life supprt techniques; AND E. The member must have a face-t-face visit with the physician respnsible fr PAD treatment t btain the referral fr SET prgram. 1) At the visit, the member must receive infrmatin regarding cardivascular disease and PAD risk factr reductin, which culd include educatin, cunseling, behaviral interventins, and utcme assessments. 2. Cntraindicatins Highmark Health Optins cnsiders SET prgrams f peripheral vascular disease (PAD) t be experimental and investigatinal fr members with abslute cntraindicatins t exercise and fr all ther indicatins because the value fr ther indicatins is nt well dcumented by the available peerreviewed literature. 3. When the SET prgram is nt cvered Supervised Exercise Therapy (SET) services are nt cvered fr cnditins ther than thse listed abve because the scientific evidence has nt been established. Highmark Health Optins cnsiders the PADnet System and testing prgram experimental and investigatinal fr evaluatin f peripheral artery disease and ther indicatins because f insufficient evidence f its effectiveness. 4. Pst-payment Audit Statement The medical recrd must include dcumentatin that reflects the medical necessity criteria and is subject t audit by Highmark Health Optins at any time pursuant t the terms f yur prvider agreement. 5. Place f Service The place f service fr SET is ambulatry utpatient, physician ffice, r hspital utpatient setting. Plicy N. MP-077-MD-DE Page 2 f 6

6. Length f Cverage Highmark Health Optins may cver SET beynd 36 sessins ver 12 weeks and may cver an additinal 36 sessins ver an extended perid f time. A secnd physician referral is required fr additinal sessins. CODING REQUIREMENTS Prcedure Cdes CPT Cde Descriptin 93668 Peripheral arterial disease (PAD) rehabilitatin, per sessin Diagnsis Cdes ICD-10 Descriptin Cdes I70.211 Athersclersis f native arteries f extremities with intermittent claudicatin, right leg I70.212 Athersclersis f native arteries f extremities with intermittent claudicatin, left leg I70.213 Athersclersis f native arteries f extremities with intermittent claudicatin, bilateral legs I70.218 Athersclersis f native arteries f extremities with intermittent claudicatin, ther extremity I70.311 Athersclersis f unspecified type f bypass graft(s) f the extremities with intermittent claudicatin, right leg I70.312 Athersclersis f unspecified type f bypass graft(s) f the extremities with intermittent claudicatin, left leg I70.313 Athersclersis f unspecified type f bypass graft(s) f the extremities with intermittent claudicatin, bilateral legs I70.318 Athersclersis f unspecified type f bypass graft(s) f the extremities with intermittent claudicatin, ther extremity I70.611 Athersclersis f nnbilgical bypass graft(s) f the extremities with intermittent claudicatin, right leg I70.612 Athersclersis f nnbilgical bypass graft(s) f the extremities with intermittent claudicatin, left leg I70.613 Athersclersis f nnbilgical bypass graft(s) f the extremities with intermittent claudicatin, bilateral legs I70.618 Athersclersis f nnbilgical bypass graft(s) f the extremities with intermittent claudicatin, ther extremity I70.711 Athersclersis f ther type f bypass graft(s) f the extremities with intermittent claudicatin, right leg I70.712 Athersclersis f ther type f bypass graft(s) f the extremities with intermittent claudicatin, left leg I70.713 Athersclersis f ther type f bypass graft(s) f the extremities with intermittent claudicatin, bilateral legs I70.718 Athersclersis f ther type f bypass graft(s) f the extremities with intermittent claudicatin, ther extremity REIMBURSEMENT Participating facilities will be reimbursed per their Highmark Health Optins cntract. Plicy N. MP-077-MD-DE Page 3 f 6

SUMMARY OF LITERATURE Peripheral artery disease (PAD) is a cmmn chrnic cardivascular cnditin that affects the lwer extremities and can substantially limit daily activities and quality f life (Heschis, 2018). Arterial bstructin and symptms f arterial insufficiency are caused by reduced bld flw (Heschis, 2018). Many PAD patients d nt have symptms but sme PAD patients develp intermittent claudicatin. Physical activity and medicatins are tw frms f treatment fr patients with PAD. Exercise therapy prvides significant benefits fr patients with PAD and symptms f intermittent claudicatin (Hageman, 2018). Supervised Exercise Therapy (SET) fr PAD is a physician referred exercise and educatin based prgram that is designed t help peple walk lnger withut pain in the hpe f imprving their verall quality f life. Accrding t the Center fr Medicare and Medicaid (2017), Research has shwn that SET is an effective, minimally invasive methd t alleviate claudicatin (the mst cmmn symptm f PAD) and may als prevent the prgressin f PAD and lwer the risk f ther cardivascular events in these patients. A Cchrane study was perfrmed n SET and included 21 trials in which a ttal f 1400 participants with intermittent claudicatin (65% male, mean age 66 years) had been assigned t either SET, hme-based exercise, r walking advice (Hageman, 2018). SET demnstrated imprvement in patients walking ability t a greater extent than the patients wh cmpleted hme-based exercise r walking advice (Hageman, 2018). Befre SET, the patients maximal pain-free walking distance was 140 meters. After three mnths f SET, patients culd walk 120 and 210 meters farther than the maximal walking distance fr thse wh fllwed a hme-based exercise prgram r received walking advice (Hageman, 2018). In May 2017, CMS annunced extended cverage fr supervised exercise therapy (SET) t treat peripheral artery disease (PAD). Accrding t CMS (2017), ther studies and trials have shwed decreases in mrtality, reduced cardivascular risk factrs, increases in capacity, and increases in quality f life in lder adults (APTA, 2017). In 2014, the Natinal Institute fr Health and Care Excellence (NICE) created guidelines and recmmendatins fr supervised exercise prgrams. The guideline des nt recmmend any hmebased exercise prgrams (NICE, 2014). Key pints in the NICE 2014 clinical evidence update include: Management f intermittent claudicatin - Exercise prgrams Supervised exercise is assciated with increases in maximal walking distance (MWD) cmpared with hme-based r ther unsupervised exercise prgrams. Supervised exercise is assciated with greater increases in walking distance in peple with art-iliac disease than either stenting r ptimum medical care. Supervised exercise appears t be mre cst effective than either angiplasty alne r supervised exercise plus angiplasty in peple with IC due t femra-ppliteal cclusin. The American Cllege f Cardilgy (ACC)/American Heart Assciatin (AHA) recmmended the SET prgrams and develped guidelines (2016): In patients with claudicatin, a supervised exercise prgram is recmmended t imprve functinal status and QL and t reduce leg symptms. (COR I) (LOE A) A supervised exercise prgram shuld be discussed as a treatment ptin fr claudicatin befre pssible revascularizatin. (COR I) (LOE B-R) Supervised exercise prgram definitins (COR I) (LOE A) Plicy N. MP-077-MD-DE Page 4 f 6

Prgram takes place in a hspital r utpatient facility Prgram uses intermittent walking exercise as the treatment mdality Prgram can be standalne r within a cardiac rehabilitatin prgram Prgram is directly supervised by qualified healthcare prvider(s) Training is perfrmed fr a minimum f 30-45 minute/sessin; sessins are perfrmed at least 3 times/week fr a minimum f 12 weeks Training invlves intermittent buts f walking t mderate-t-maximum claudicatin, alternating with perids f rest Warm-up and cl-dwn perids precede and fllw each sessin f walking POLICY SOURCE(S) Centers fr Medicare and Medicaid Services: Medicare Natinal Cverage Determinatin fr Supervised Exercise Therapy fr Symptmatic Peripheral Artery Disease (PAD) (NCD 20.35) Publicatin N. 100-3, Versin 1. Effective Date 5/25/2017. Accessed n Octber 5, 2018. Centers fr Medicare and Medicaid Services: Decisin mem fr Supervised Exercise Therapy (SET) fr Symptmatic Peripheral Artery Disease (PAD) (CAG-00449N).May 25, 2017. Accessed n Octber 5, 2018. Hayes, Inc. Supervised Exercise Therapy (SET) fr the Treatment f Symptmatic Peripheral Artery Disease (PAD). Publicatin Date: July 13, 2017. Accessed n Octber 5, 2018. Natinal Institute fr Health and Care Excellence (NICE). Lwer limb peripheral arterial disease. Evidence update Nvember 2014. Evidence Update 69. Lndn, UK: NICE; Nvember 2014. Accessed n Octber 5, 2018. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Assciatin fr Vascular Surgery; Sciety fr Vascular Surgery; Sciety fr Cardivascular Angigraphy and Interventins; Sciety fr Vascular Medicine and Bilgy; Sciety f Interventinal Radilgy; ACC/AHA Task Frce n Practice Guidelines Writing Cmmittee t Develp Guidelines fr the Management f Patients With Peripheral Arterial Disease; American Assciatin f Cardivascular and Pulmnary Rehabilitatin; Natinal Heart, Lung, and Bld Institute; Sciety fr Vascular Nursing; TransAtlantic Inter-Sciety Cnsensus; Vascular Disease Fundatin. ACC/AHA 2005 Practice Guidelines fr the management f patients with peripheral arterial disease (lwer extremity, renal, mesenteric, and abdminal artic): A cllabrative reprt frm the American Assciatin fr Vascular Surgery/Sciety fr Vascular Surgery, Sciety fr Cardivascular Angigraphy and Interventins, Sciety fr Vascular Medicine and Bilgy, Sciety f Interventinal Radilgy, and the ACC/AHA Task Frce n Practice Guidelines (Writing Cmmittee t Develp Guidelines fr the Management f Patients With Peripheral Arterial Disease): Endrsed by the American Assciatin f Cardivascular and Pulmnary Rehabilitatin; Natinal Heart, Lung, and Bld Institute; Sciety fr Vascular Nursing; TransAtlantic Inter-Sciety Cnsensus; and Vascular Disease Fundatin. J Am Cll Cardil. 2006;47(6):1239-1312. Accessed n Octber 5, 2018. Heschis, D.G., Glden, M.A. Clinical features and diagnsis f lwer extremity peripheral artery disease. UpTDate, June 11, 2018. Accessed n Octber 5, 2018. Plicy N. MP-077-MD-DE Page 5 f 6

Hageman, D., Fkkenrd, HJP. Supervised exercise therapy vs hme-based exercise therapy vs walking advice fr patients with leg pain while walking (intermittent claudicatin). April 8, 2018. Accessed n Octber 5, 2018. Plicy Histry: Date Activity 10/03/2018 Initial plicy develped 12/11/2018 QI/UM Cmmittee apprval 02/18/2019 Prvider effective date Plicy N. MP-077-MD-DE Page 6 f 6